These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 39333782)
1. Revisiting the survival paradox between stage IIB/C and IIIA colon cancer. Yu C; Shi Z; Zhou G; Chang X Sci Rep; 2024 Sep; 14(1):22133. PubMed ID: 39333782 [TBL] [Abstract][Full Text] [Related]
2. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system? Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828 [TBL] [Abstract][Full Text] [Related]
3. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer. Li H; Fu G; Wei W; Huang Y; Wang Z; Liang T; Tian S; Chen H; Zhang W Front Oncol; 2020; 10():595107. PubMed ID: 33312954 [TBL] [Abstract][Full Text] [Related]
4. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163 [TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer. Chu QD; Zhou M; Medeiros K; Peddi P Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043 [TBL] [Abstract][Full Text] [Related]
6. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer. Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox. Kim HS; Kim KM; Lee SB; Kim GR; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS J Surg Oncol; 2019 Sep; 120(3):423-430. PubMed ID: 31134644 [TBL] [Abstract][Full Text] [Related]
8. Staging Paradox and recurrence pattern among stage IIB, IIC, and IIIA Colon cancers: a retrospective cohort study. Liao YT; Huang J; Hung JS; Huang KW; Liang JT Int J Colorectal Dis; 2024 Oct; 39(1):161. PubMed ID: 39397211 [TBL] [Abstract][Full Text] [Related]
9. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. O'Connell JB; Maggard MA; Ko CY J Natl Cancer Inst; 2004 Oct; 96(19):1420-5. PubMed ID: 15467030 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma. Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859 [TBL] [Abstract][Full Text] [Related]
11. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? Hari DM; Leung AM; Lee JH; Sim MS; Vuong B; Chiu CG; Bilchik AJ J Am Coll Surg; 2013 Aug; 217(2):181-90. PubMed ID: 23768788 [TBL] [Abstract][Full Text] [Related]
12. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, Prognosis, and Management in Stage I-III Colon Cancer after Surgery: A Retrospective Cohort Study in the SEER Database. Zhang Q; Wang L; Sun R; Gao J; Liu T Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496 [TBL] [Abstract][Full Text] [Related]
13. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database. Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous survival between stage IIA and stage IIIA colon cancer when different numbers of lymph nodes are harvested. Huang B; Feng Y; Ni M; Chen C; Cai G ANZ J Surg; 2018 Apr; 88(4):316-321. PubMed ID: 27580642 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomy. Wu SG; Wang J; Lian CL; Lei J; Hua L; Lin Q; Chen YX; He ZY Breast; 2020 Jun; 51():2-10. PubMed ID: 32172191 [TBL] [Abstract][Full Text] [Related]
16. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients. Abdel-Rahman O Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248 [TBL] [Abstract][Full Text] [Related]
17. Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non-small cell lung cancer tumor-node-metastasis staging. Cai J; Li Y; Yang F Cancer Med; 2024 Jul; 13(14):e70018. PubMed ID: 39045904 [TBL] [Abstract][Full Text] [Related]
18. External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program. Tjokrowidjaja A; Browne L; Soudy H Asia Pac J Clin Oncol; 2022 Oct; 18(5):e280-e288. PubMed ID: 34811927 [TBL] [Abstract][Full Text] [Related]
19. Survival Contradiction in Stage II, IIIA, And IIIB Colon Cancer: A Surveillance, Epidemiology, and End Result-Based Analysis. Li Y; Hua R; He J; Zhang H Evid Based Complement Alternat Med; 2022; 2022():4088117. PubMed ID: 36437824 [TBL] [Abstract][Full Text] [Related]
20. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer. Abdel-Rahman O Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]